| Drug Name |
Thioguanine |
| Drug ID |
BADD_D02199 |
| Description |
An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia. |
| Indications and Usage |
For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias. |
| Marketing Status |
approved |
| ATC Code |
L01BB03 |
| DrugBank ID |
DB00352
|
| KEGG ID |
D06109
|
| MeSH ID |
D013866
|
| PubChem ID |
2723601
|
| TTD Drug ID |
D02ZXM
|
| NDC Product Code |
76388-880; 50683-0356; 80725-630; 69784-630 |
| UNII |
FTK8U1GZNX
|
| Synonyms |
Thioguanine | 2-Amino-6-Purinethiol | 2 Amino 6 Purinethiol | Tioguanine | 6-Thioguanine | 6 Thioguanine | Tabloid | Thioguanine Tabloid | Thioguanin-GSK | Thioguanin GSK | ThioguaninGSK | Tioguanina Wellcome | Thioguanine Hemihydrate | Thioguanine Monosodium Salt | Lanvis | Thioguanine Anhydrous | Anhydrous, Thioguanine |
